New research in mice suggests that gains in functional recovery from spinal cord injuries may be possible, thanks to a molecule known as Lin28, which regulates cell growth.
In a study published recently in Molecular Therapy, the researchers, from Lewis Katz School of Medicine Temple University (LKSOM), describe the ability of Lin28 — when expressed above its usual levels — to fuel axon regrowth in mice with spinal cord injury or optic nerve injury, enabling repair of the body’s communication grid.
“Our findings show that Lin28 is a major regulator of axon regeneration and a promising therapeutic target for central nervous system injuries,” Shuxin Li, MD, PhD, Professor of Anatomy and Cell Biology and in the Shriners Hospitals Pediatric Research Center at the Lewis Katz School of Medicine at Temple University and senior investigator on the new study, explains in a media release.
“We became interested in Lin28 as a target for neuron regeneration because it acts as a gatekeeper of stem cell activity,” Li adds. “It controls the switch that maintains stem cells or allows them to differentiate and potentially contribute to activities such as axon regeneration.”
To explore the effects of Lin28 on axon regrowth, Li and colleagues developed a mouse model in which animals expressed extra Lin28 in some of their tissues. When full-grown, the animals were divided into groups that sustained spinal cord injury or injury to the optic nerve tracts that connect to the retina in the eye.
Another set of adult mice, with normal Lin28 expression and similar injuries, were given injections of a viral vector (a type of carrier) for Lin28 to examine the molecule’s direct effects on tissue repair.
Extra Lin28 stimulated long-distance axon regeneration in all instances, though the most dramatic effects were observed following post-injury injection of Lin28. In mice with spinal cord injury, Lin28 injection resulted in the growth of axons to more than three millimeters beyond the area of axon damage, while in animals with optic nerve injury, axons regrew the entire length of the optic nerve tract. Evaluation of walking and sensory abilities after Lin28 treatment revealed significant improvements in coordination and sensation, the release explains.
“We observed a lot of axon regrowth, which could be very significant clinically, since there currently are no regenerative treatments for spinal cord injury or optic nerve injury,” Li comments.
One of his goals in the near-term is to identify a safe and effective means of getting Lin28 to injured tissues in human patients. To do so, his team of researchers will need to develop a vector, or carrier system for Lin28, that can be injected systemically and then hone in on injured axons to deliver the therapy directly to multiple populations of damaged neurons.
Li further wants to decipher the molecular details of the Lin28 signaling pathway, the release continues.
“Lin28 associates closely with other growth signaling molecules, and we suspect it uses multiple pathways to regulate cell growth,” he explains. These other molecules could potentially be packaged along with Lin28 to aid neuron repair.
[Source(s): Temple University Health System, Science Daily]